Your browser doesn't support javascript.
Evaluation of cardiac parameters between survivors and nonsurvivors of COVID-19 patients.
Ozdin, Mehmet; Yazar, Hayrullah; Yaylaci, Selcuk; Koroglu, Mehmet; Genc, Ahmed Cihad; Kocayigit, Ibrahim; Genc, Ahmed Bilal; Yildirim, Ilhan; Kocayigit, Havva; Karabay, Oguz.
  • Ozdin M; Sakarya University Education and Research Hospital, Medical Biochemistry Laboratory - Sakarya, Turkey.
  • Yazar H; Sakarya University Education and Research Hospital, Medical Biochemistry Laboratory - Sakarya, Turkey.
  • Yaylaci S; Sakarya University, Faculty of Medicine, Department of Medical Biochemistry - Sakarya, Turkey.
  • Koroglu M; Sakarya University, Faculty of Medicine, Department of Internal Medicine - Sakarya, Turkey.
  • Genc AC; Sakarya University, Faculty of Medicine, Department of Medical Microbiology - Sakarya, Turkey.
  • Kocayigit I; Sakarya University, Faculty of Medicine, Department of Internal Medicine - Sakarya, Turkey.
  • Genc AB; Sakarya University, Faculty of Medicine, Department of Cardiology - Sakarya, Turkey.
  • Yildirim I; Sakarya University, Faculty of Medicine, Department of Internal Medicine - Sakarya, Turkey.
  • Kocayigit H; Sakarya University, Faculty of Medicine, Department of Internal Medicine - Sakarya, Turkey.
  • Karabay O; Sakarya University, Faculty of Medicine, Department of Anesthesiology and Reanimation - Sakarya, Turkey.
Rev Assoc Med Bras (1992) ; 67Suppl 1(Suppl 1): 80-85, 2021.
Article in English | MEDLINE | ID: covidwho-1362148
ABSTRACT

OBJECTIVE:

The present study compares the cardiac parameters of the survivor and nonsurvivor patients with COVID-19 infection.

METHODS:

This study was conducted in 379 patients diagnosed with COVID-19 disease. Information of 21 nonsurvivor and 358 survivor patients with COVID-19 was obtained from the hospital information management system and analyzed retrospectively. Relationship between cardiac parameters in patients categorized into the mortal and immortal groups was investigated.

RESULTS:

Of the total 379 patients involved in this study, 155 (40.9%) were females and 224 (59.1%) were males. No statistically significant difference in mortality was found between females and males (p=0.249). The total median age was 70, the median age in the nonsurvivor group was 74 (35-89), and it was 69.5 (18-96) in the survivor group (p=0.249). The median values of high-sensitivity troponin (hs-Tn), creatine kinase MB form, and especially myoglobin in the survivor and nonsurvivor groups were 25/64.9 (p=0.028), 18/23 (p=0.02), and 105.5/322.4 (p<0.001), and the difference was statistically significant. Comparing mortality, while there was 1 (0.7%) nonsurvivor out of 134 patients in the service unit, there were 20 (8.2%) nonsurvivors out of 245 patients in the intensive care unit. This difference was statistically significant (p=0.003). The cutoff value of myoglobin, which may pose a risk of mortality, was found to be 191.4 µg/L, while it was 45.7 ng/l for hs-Tn and 60.1 U/L for creatine kinase MB.

CONCLUSIONS:

Advanced age and increased levels of high-sensitivity troponin, creatine kinase MB, and myoglobin were found to be associated with mortality.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Rev Assoc Med Bras (1992) Year: 2021 Document Type: Article Affiliation country: 1806-9282.67.Suppl1.20200848

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Rev Assoc Med Bras (1992) Year: 2021 Document Type: Article Affiliation country: 1806-9282.67.Suppl1.20200848